Prevalence of nonrefractive visual impairment in US adults and associated risk factors, 1999-2002 and 2005-2008

JAMA

Volumn 308, Issue 22, 2012, Pages 2361-2368

  Ko, Fang ^a   Vitale, Susan ^c   Chou, Chiu Fang ^d   Cotch, Mary Frances ^c   Saaddine, Jinan ^d   Friedman, David S ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c NATIONAL EYE INSTITUTE   (United States)

^d NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE DURATION; EDUCATIONAL STATUS; FEMALE; GROUPS BY AGE; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POVERTY; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; RISK FACTOR; UNITED STATES; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 84870897491     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2012.85685     Document Type: Article

References (37)

1. Vitale S, Cotch MF, Sperduto RD. Prevalence of visual impairment in the United States. JAMA. 2006;295(18):2158-2163.
2. Congdon N, O'Colmain B, Klaver CC, et al; Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122(4):477-485.
3. Zambelli-Weiner A, Crews JE, Friedman DS. Disparities in Adult Vision Health in the United States [published online ahead of print May 23, 2012]. Am J Ophthalmol. DOI:10.1016/j.ajo.2012.03.018.
4. Zhang X, Gregg EW, Cheng YJ, et al. Diabetes mellitus and visual impairment: national health and nutrition examination survey, 1999-2004. Arch Ophthalmol. 2008;126(10):1421-1427.
5. Kempen JH, O'Colmain BJ, Leske MC, et al; Eye Diseases Prevalence Research Group. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol. 2004;122(4):552-563.
6. Zhang X, Saaddine JB, Chou CF, et al. Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA. 2010;304(6):649-656.
7. Fong DS, Aiello L, Gardner TW, et al; American Diabetes Association. Retinopathy in diabetes. Diabetes Care. 2004;27(suppl 1):S84-S87.
8. Klein R, Klein B. Vision disorders in diabetes. In: National Diabetes Data Group, ed. Diabetes in America. 2nd ed. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1995:293-337.
9. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States, 2011. Atlanta, GA: US Dept of Health and Human Services, Centers for Disease Control and Prevention; 2011.
10. Cheung BM, Ong KL, Cherny SS, Sham PC, Tso AW, Lam KS. Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006. Am J Med. 2009;122(5):443-453.
11. Mokdad AH, Ford ES, Bowman BA, et al. Diabetes trends in the US: 1990-1998. Diabetes Care. 2000;23(9):1278-1283.
12. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP. The continuing epidemics of obesity and diabetes in the United States. JAMA. 2001;286(10):1195-1200.
13. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2007. Atlanta, GA: US Dept of Health and Human Services, Centers for Disease Control and Prevention; 2007.
14. Acton KJ, Burrows NR, Moore K, Querec L, Geiss LS, Engelgau MM. Trends in diabetes prevalence among American Indian and Alaska native children, adolescents, and young adults. Am J Public Health. 2002;92(9):1485-1490.
15. de Boer IH, Rue TC, Hall YN, Heagerty PJ, Weiss NS, Himmelfarb J. Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA. 2011;305(24):2532-2539.
16. National Health and Nutrition Examination Survey. Public-use data files. http://www.cdc.gov/nchs/about/major/nhanes/datalink.htm. Accessed November 14, 2012.
17. Berglund PA. Getting the most out of the SAS survey procedures: repeated replication methods, subpopulation analysis, and missing data options in SAS v9.2. Paper presented at: SAS Global Forum 2009; March 22-25, 2009; Washington, DC. Paper 246-2009.
18. Yuan YC. Multiple Imputation for Missing Data: Concepts and New Development. Rockville, MD: SAS institute Inc; 2000.
19. National Health and Nutrition Examination Survey. Vision Procedures Manual. http://www.cdc.gov/nchs/data/nhanes/nhanes-01-02/vision-year-3.pdf. Accessed November 14, 2012.
20. National Health and Nutrition Examination Survey. Laboratory Procedure Manual. http://www.cdc.gov/nchs/data/nhanes/nhanes-07-08/glu-e-met-fasting- glucose-ModP.pdf. Accessed November 14, 2012.
21. Palaniappan L, Carnethon M, Fortmann SP. Association between microalbuminuria and the metabolic syndrome: NHANES III. Am J Hypertens. 2003;16(11 pt 1):952-958.
22. Beydoun MA, Wang Y. Gender-ethnic disparity in BMI and waist circumference distribution shifts in US adults. Obesity (Silver Spring). 2009;17(1):169-176.
23. National Health and Nutrition Examination Survey. Analytic and Reporting Guidelines. http://www.cdc.gov/nchs/data/nhanes/nhanes-03-04/nhanes-analytic- guidelines-dec-2005.pdf. Accessed July 22, 2012.
24. National Health and Nutrition Examination Survey. Hypothesis testing. http://www.cdc.gov/nchs/tutorials/nhanes/NHANESAnalyses/HypothesisTesting/ hypothesis-testing-intro.htm. Accessed September 8, 2012.
25. Pinhas-Hamiel O, Zeitler P. The global spread of type 2 diabetes mellitus in children and adolescents. J Pediatr. 2005;146(5):693-700.
26. Fagot-Campagna A, Pettitt DJ, Engelgau MM, et al. Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective. J Pediatr. 2000;136(5):664-672.
27. Kaufman FR. Type 2 diabetes mellitus in children and youth: a new epidemic. J Pediatr Endocrinol Metab. 2002;15(suppl 2):737-744.
28. Lytle LA. Dealing with the childhood obesity epidemic: a public health approach [published online ahead of print March 7, 2012]. Abdom Imaging. DOI: 10.1007/s00261-012-9861-y.
29. Klein R, Barrett-Connor EL, Blunt BA, Wingard DL. Visual impairment and retinopathy in people with normal glucose tolerance, impaired glucose tolerance, and newly diagnosed NIDDM. Diabetes Care. 1991;14(10):914-918.
30. Centers for Disease Control and Prevention (CDC). Self-reported visual impairment among persons with diagnosed diabetes - United States, 1997-2010. MMWR Morb Mortal Wkly Rep. 2011;60(45):1549-1553.
31. Klein R, Lee KE, Gangnon RE, Klein BE. The 25-year incidence of visual impairment in type 1 diabetes mellitus the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Ophthalmology. 2010;117(1):63-70.
32. Lecaire T, Palta M, Zhang H, Allen C, Klein R, D'Alessio D. Lower-than-expected prevalence and severity of retinopathy in an incident cohort followed during the first 4-14 years of type 1 diabetes: the Wisconsin Diabetes Registry Study. Am J Epidemiol. 2006;164(2):143-150.
33. Hovind P, Tarnow L, Rossing K, et al. Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care. 2003;26(4):1258- 1264.
34. Klein R, Klein BE. Are individuals with diabetes seeing better?: a long-term epidemiological perspective. Diabetes. 2010;59(8):1853-1860.
35. Cugati S, Kifley A, Mitchell P, Wang JJ. Temporal trends in the age-specific prevalence of diabetes and diabetic retinopathy in older persons: population-based survey findings. Diabetes Res Clin Pract. 2006;74(3):301-308.
36. Frick KD, Gower EW, Kempen JH, Wolff JL. Economic impact of visual impairment and blindness in the United States. Arch Ophthalmol. 2007;125(4):544-550.
37. Roberts CB, Hiratsuka Y, Yamada M, et al. Economic cost of visual impairment in Japan. Arch Ophthalmol. 2010;128(6):766-771.